Frankfurt - Delayed Quote EUR

Zeus Capital SICAV DNA Biotech Z Acc (0P0001N724.F)

89.27 +0.62 (+0.70%)
As of June 25 at 10:00 PM GMT+2. Market Open.

Top 10 Holdings (45.17% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 6.78%
REGN
Regeneron Pharmaceuticals, Inc. 6.56%
MRK
Merck & Co., Inc. 6.04%
VRTX
Vertex Pharmaceuticals Incorporated 5.26%
ABBV
AbbVie Inc. 4.55%
CGEN.TA
Compugen Ltd. 3.60%
NVS
Novartis AG 3.52%
HRTX
Heron Therapeutics, Inc. 3.14%
SNY
Sanofi 2.93%
GSK
GSK plc 2.79%

Sector Weightings

Sector0P0001N724.F
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 13.52%
Stocks 86.48%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P0001N724.F Category Average
Price/Earnings 0.04 --
Price/Book 0.21 --
Price/Sales 0.18 --
Price/Cashflow 0.06 --
Median Market Cap 24,385.42 --
3 Year Earnings Growth -7.3 --

Bond Holdings

Performance & Risk

YTD Return 0.00%
5y Average Return 0.00%
Rank in Category (ytd) 47
% Rank in Category (ytd) --
Beta (5Y Monthly) --
Morningstar Risk Rating --

Fund Overview

Category --
Fund Family Zeus Asset Management S.A.
Net Assets 1.72M
YTD Return 5.31%
Yield 0.00%
Morningstar Rating --
Inception Date Jul 26, 2021

Fund Summary

Related Tickers